Clinical Trials Browser

Interventional × Carcinoma, Renal Cell × vandetanib × Clear all

NCT02495103 2021-01-26

Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma

Phase 1/2 Terminated

7 enrolled 10 charts

Carcinoma, Renal Cell

NCT00566995 2018-10-30

Phase II Study of Vandetanib in Individuals With Kidney Cancer

Phase 2 Completed

37 enrolled 16 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT01372813 2015-10-23

Vandetanib to Treat Advanced Kidney Cancer

Phase 2 Terminated

3 enrolled 10 charts

Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasms